Immuno-Biological Laboratories Co Ltd
TSE:4570
Dividends
Dividend Yield
Immuno-Biological Laboratories Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Immuno-Biological Laboratories Co Ltd
Immuno-Biological Laboratories Co Ltd have
decreased
by 0%.
Payout Ratio
Immuno-Biological Laboratories Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Immuno-Biological Laboratories Co Ltd is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Immuno-Biological Laboratories Co Ltd
| Average Annual Return | 1.98% |
| Standard Deviation of Annual Returns | 39.67% |
| Max Drawdown | -64% |
| Market Capitalization | 13.4B JPY |
| Shares Outstanding | 9 310 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Immuno-Biological Laboratories Co Ltd's latest stock split occurred on Sep 26, 2013
The company executed a 10-for-1 stock split, meaning that for every share held, investors received 10 new shares.
Before the split, Immuno-Biological Laboratories Co Ltd traded at 1517 per share. Afterward, the share price was about 1680.
The adjusted shares began trading on Sep 26, 2013. This was the only stock split in Immuno-Biological Laboratories Co Ltd's history.
